Form: CORRESP

A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

January 17, 2017

 

 

 

January 17, 2017

 

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

*100 F. Street, N.E.

Washington, D.C. 20549

 

Re: AntriaBio, Inc. (the "Company")

Registration Statement on Form S-1

File No. 333-214974

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 2:00PM on January 19, 2017 or as soon thereafter as is practicable.

 

 

  Very truly yours,
   
  ANTRIABIO, INC.
   
  By:   /s/ Nevan Elam                   
  Name:  Nevan Elam
  Title:    Chief Executive Officer